Cargando…
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome
Chemokines are important in the development and progression of tumors. We investigated the expression of CXCL14 and CXCL16 in colon cancer. Expression of mRNA was assessed in primary tumors and lymph nodes and CXCL16 mRNA levels were correlated to patient’s survival. Protein expression was investiga...
Autores principales: | AbdelMageed, Manar, Ali, Haytham, Olsson, Lina, Lindmark, Gudrun, Hammarström, Marie-Louise, Hammarström, Sten, Sitohy, Basel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888697/ https://www.ncbi.nlm.nih.gov/pubmed/31752131 http://dx.doi.org/10.3390/ijms20225793 |
Ejemplares similares
-
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
por: AbdelMageed, Manar, et al.
Publicado: (2021) -
Ectopic expression of the chemokine CXCL17 in colon cancer cells
por: Ohlsson, Lina, et al.
Publicado: (2016) -
Prognostic Significance of GPR55 mRNA Expression in Colon Cancer
por: Ismail, Hager Tarek H., et al.
Publicado: (2022) -
Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis
por: Olsson, Lina, et al.
Publicado: (2020) -
CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer
por: Olsson, Lina M., et al.
Publicado: (2021)